Mainz Biomed N.V (MYNZ) Gross Profit: 2021-2025
Historic Gross Profit for Mainz Biomed N.V (MYNZ) over the last 2 years, with Jun 2025 value amounting to $9.5 million.
- Mainz Biomed N.V's Gross Profit rose 11.98% to $9.5 million in Q2 2025 from the same period last year, while for Jun 2025 it was $31.3 million, marking a year-over-year increase of 254.62%. This contributed to the annual value of $574,883 for FY2024, which is 12.80% up from last year.
- According to the latest figures from Q2 2025, Mainz Biomed N.V's Gross Profit is $9.5 million, which was down 28.49% from $13.2 million recorded in Q4 2024.
- Mainz Biomed N.V's 5-year Gross Profit high stood at $13.2 million for Q4 2024, and its period low was $18,613 during Q3 2022.
- Moreover, its 3-year median value for Gross Profit was $148,798 (2023), whereas its average is $4.5 million.
- In the last 5 years, Mainz Biomed N.V's Gross Profit tumbled by 99.64% in 2022 and then skyrocketed by 9,725.41% in 2024.
- Quarterly analysis of 5 years shows Mainz Biomed N.V's Gross Profit stood at $10.0 million in 2021, then tumbled by 99.64% to $36,296 in 2022, then skyrocketed by 271.21% to $134,734 in 2023, then skyrocketed by 9,725.41% to $13.2 million in 2024, then climbed by 11.98% to $9.5 million in 2025.
- Its last three reported values are $9.5 million in Q2 2025, $13.2 million for Q4 2024, and $8.5 million during Q2 2024.